TELA Bio, Inc. ·

TELA 8-K 2026-08-04

TELA Bio, Inc. (TELA) 8-K dated 2026-08-04 — accession 0001104659-26-090056. This URL is the filing, not the TELA hub.

TELA Bio, Inc. (TELA) is a medical devices company listed on NASDAQ.

TELA Bio, Inc. filed a 8-K on 2026-08-04. Accession 0001104659-26-090056.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.

Not investment advice. The TELA SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR